Clinical Trial Update: Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating 24-hour intragastric pH profiles after administration of esomeprazole, lansoprazole, and pantoprazole in Hispanic patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Esomeprazole (Esomeprazole)
• Lansoprazole (Lansoprazole)
• Pantoprazole (pantoprazole)

Snippet

Sponsor: AstraZeneca | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: COMPLETED